Postoperative adverse events and long-term survival after cytoreductive surgery and intraperitoneal chemotherapy
- 1 February 2009
- journal article
- research article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 35 (2) , 202-208
- https://doi.org/10.1016/j.ejso.2008.04.002
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Early Results of Surgery in 123 Patients with Pseudomyxoma Peritonei from a Perforated Appendiceal NeoplasmDiseases of the Colon & Rectum, 2007
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus StatementAnnals of Surgical Oncology, 2006
- Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: The experience of National Cancer Institute of MilanEuropean Journal of Surgical Oncology, 2006
- Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary studyBritish Journal of Cancer, 2004
- Palliative Treatment of Patients with Colorectal CancerScandinavian Journal of Surgery, 2003
- Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritoneiBritish Journal of Surgery, 2001
- Morbidity and Mortality Analysis of 200 Treatments With Cytoreductive Surgery and Hyperthermic Intraoperative Intraperitoneal Chemotherapy Using the Coliseum TechniqueAnnals of Surgical Oncology, 1999
- Influence of metastatic site as an additional predictor for response and outcome in advanced colorectal carcinomaBritish Journal of Cancer, 1999
- The prognostic importance of peritoneal involvement in colonic cancer: A prospective evaluationGastroenterology, 1997
- Prognosis after surgery in patients with incurable rectal cancer: A population-based studyBritish Journal of Surgery, 1996